This pilot study is designed to test the logistics and recruitment of a trial testing the benefit of sodium nitrate in the prevention of contrast-associated kidney injury in a group of patients at high-risk.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percent of participants receiving the first dose of blinded study drug within 1-8 hours prior to contrast exposure
Timeframe: Approximately 34 days
Percent of participants completing full course of 4 doses of blinded study drug
Timeframe: Approximately 34 days
Percent of participants with 48-hour basic metabolic panel collected between 36-108 hours of contrast exposure
Timeframe: Approximately 34 days
Percent of participants who had completion of clinical outcome monitoring at 30-day follow-up interview
Timeframe: Approximately 34 days
Percent of participants recruited to the trial for undergoing coronary angiogram
Timeframe: Approximately 34 days
Percent of participants recruited to the trial for undergoing a contrast-enhanced CT scan
Timeframe: Approximately 34 days